Kathmandu. Kantipur Pharmaceuticals Lab Limited has received permission from the Securities Board of Nepal (SEBON) for the IPO issuance and sale. The company has received permission to sell 17 lakh units of shares worth Rs 17 crore on November 3. Muktinath Capital has been appointed as the issue manager for the IPO issuance.
The company is engaged in research in veterinary medicines and the production and sale of dietary supplements for livestock.
